Stage FocusPre-Seed, Seed, Series A
GeographySwitzerland, Europe
TypeVC
Last Activity2026
Industry Focus
Industries
MedtechRoboticsSemiconductorsNeurotechAICybersecurityEnergy TechClimate TechAgritechFood Tech
Technical BenchLimited
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Privilège Ventures is a Swiss, FINMA-authorized early-stage venture capital firm based in Lugano, co-founded in 2021 by Jacqueline Ruedin Rüsch, who spent nearly three decades in Swiss private banking and asset management before entering venture capital in 2014, and Angelica Morrone, a former investment banker who founded her own US asset-management firm. The firm invests in HealthTech, MedTech, a...
Notable Investments
D
DistalmotionI
IDUN TechnologiesX
XsensioQ
Quantum SiliconB
Bin1ATEH
HydromeaC
CyltronicE
EnantiosA
AveloA
Annaida TechnologiesA
AdipossG
GeosatisSimilar Funds
JP
Joyance Partners
United States
GeneralistMedtechBiotechFood TechPre-SeedSeed
NV
Necessary Ventures
San Francisco, United States
DeepTech NativeMedtechBiotechRoboticsPre-SeedSeed
VV
Vorwerk Ventures
Berlin, Germany
GeneralistMedtechFood TechClimate TechPre-SeedSeed
MV
MatterScale Ventures
New York, United States
GeneralistMedtechFood TechEnergy TechPre-SeedSeed
N
NZVC
Auckland, New Zealand
Pure DeepTechAerospaceRoboticsAIPre-SeedSeed
SOSV
New York, United States
Pure DeepTechSynthetic BiologyClimate TechRoboticsPre-SeedSeed